Finally, while we validated the relative expression of HSPB1 using qRT-PCR analysis, it is necessary to thoroughly investigate the mechanisms by which these seven genes modulate T cell depletion in gliomas in order to better integrate risk assessment and clinical practice. The gene discussed is HSPB1; the disease is central nervous system cancer.